1
|
Parker J, Ioannides J, Kumaratunga V, Preston J, Hartley C, Donaldson D. Subpalpebral lavage placement for remote topical administration of ocular medications in 12 dogs: A retrospective review and assessment of owner perception. Vet Ophthalmol 2022; 26:108-120. [PMID: 36239227 DOI: 10.1111/vop.13029] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/06/2021] [Revised: 09/25/2022] [Accepted: 09/26/2022] [Indexed: 11/27/2022]
Abstract
OBJECTIVE The aim of this study was to describe the placement of subpalpebral lavage (SPL) systems in 12 dogs (15 eyes) intolerant of topical ocular medications to assess the suitability, complications encountered and owner perception of use. ANIMALS STUDIED Retrospective review of dogs that underwent SPL placement for treatment of ocular disease at the Ophthalmology Department, University of Bristol Small Animal Hospital between 2017 and 2021. PROCEDURE(S) Data recorded included signalment, history, diagnosis, treatment, reason for SPL placement, uni- or bilateral placement, duration of placement, complications, and outcome. Owner perception was assessed using an online questionnaire. Statistical analysis included McNemar and Wilcoxon signed-ranks tests. RESULTS Twelve dogs (15 eyes) underwent SPL placement. Eleven owners completed the online questionnaire. Corneal ulceration was the most common disease requiring SPL placement (n = 13/15 eyes, 86.7%). Most cases received multimodal topical therapy (n = 9/15 eyes, 60.0%) via SPL. Owners administered medication 6.63 times daily via SPL (range 1-16 applications/day). All dogs requiring ongoing topical medication (n = 8/12, 66.7%) were trained to accept direct administration during SPL treatment. Statistically significant improvements in medication compliance, ease of application, and reduced perceived risk of iatrogenic ocular injury were reported by owners (p-value = .001, .004, and .031 respectively). Minor complications were infrequently reported but an excellent outcome was achieved for all eyes. CONCLUSION Subpalpebral lavage placement provides a practical and safe solution for the provision of frequent multimodal ocular medication when treating patients with a challenging temperament.
Collapse
Affiliation(s)
- Josie Parker
- Ophthalmology Department, Hospital for Small Animals Royal (Dick) School of Veterinary Studies, University of Edinburgh, Roslin, UK
| | | | - Vim Kumaratunga
- Ophthalmology Department, The Queen Mother Hospital for Animals, Royal Veterinary College, Hatfield, UK
| | - Juliette Preston
- Ophthalmology Department, The Queen Mother Hospital for Animals, Royal Veterinary College, Hatfield, UK
| | - Claudia Hartley
- Ophthalmology Department, Hospital for Small Animals Royal (Dick) School of Veterinary Studies, University of Edinburgh, Roslin, UK
| | - David Donaldson
- Ophthalmology Department, The Queen Mother Hospital for Animals, Royal Veterinary College, Hatfield, UK
| |
Collapse
|
2
|
Cernicchiaro N, Oliveira ARS, Hanthorn C, Renter DG. Outcomes research: origins, relevance, and potential impacts for veterinary medicine. J Am Vet Med Assoc 2022; 260:714-723. [DOI: 10.2460/javma.21.06.0318] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
Affiliation(s)
- Natalia Cernicchiaro
- Center for Outcomes Research and Epidemiology (CORE), College of Veterinary Medicine, Kansas State University, Manhattan, KS
| | - Ana R. S. Oliveira
- Center for Outcomes Research and Epidemiology (CORE), College of Veterinary Medicine, Kansas State University, Manhattan, KS
| | - Christy Hanthorn
- Center for Outcomes Research and Epidemiology (CORE), College of Veterinary Medicine, Kansas State University, Manhattan, KS
| | - David G. Renter
- Center for Outcomes Research and Epidemiology (CORE), College of Veterinary Medicine, Kansas State University, Manhattan, KS
| |
Collapse
|
3
|
Roeber F, Webster M. Protecting dogs and cats against the Australian paralysis tick, Ixodes holocyclus (Acari: Ixodidae): A review of the Australian acaricide registration process. CURRENT RESEARCH IN PARASITOLOGY & VECTOR-BORNE DISEASES 2021; 1:100054. [PMID: 35284866 PMCID: PMC8906080 DOI: 10.1016/j.crpvbd.2021.100054] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 08/11/2021] [Revised: 09/27/2021] [Accepted: 10/08/2021] [Indexed: 11/13/2022]
Abstract
Tick control is mainly achieved through the use of effective ectoparasiticides that can be either dermally or systemically distributed in/on the host. Before any acaricide can be legally made available to veterinarians and pet owners, it must demonstrate efficacy in a series of well-designed dose confirmation studies. The data generated during these studies are then reviewed by government regulators and used for the registration of the acaricide. In Australia, the most significant tick species is the Australian paralysis tick, Ixodes holocyclus. This three-host tick produces a potent neurotoxin (holocyclotoxin) that induces a rapidly ascending flaccid paralysis that can be fatal to companion animals and larger mammals such as cattle and horses. The Australian Pesticides and Veterinary Medicines Authority (APVMA) is the national Australian regulator which sets the data requirements for the registration of acaricides. This paper reviews the requirements set by the APVMA and puts them in direct context with the biology, distribution and reported acaricide susceptibility of I. holocyclus. An overview of acaricides currently registered in Australia for the control of I. holocyclus in dogs and cats, their reported efficacy data and the conduct of I. holocyclus efficacy trials are also provided. A review of the requirements for the conduct of acaricide efficacy trials for Ixodes holocyclus was undertaken. The requirements of the Australian government regulator were put in direct context with the biology of the species. The need for the inclusion of Far North Queensland ticks into tick studies needs to be further assessed. At present, there is no evidence of acaricide resistance in Ixodes holocyclus.
Collapse
|
4
|
Awareness of tick-borne disease and compliance with using tick preventive products of dog owners in Hong Kong. Prev Vet Med 2017; 137:97-100. [PMID: 28034594 DOI: 10.1016/j.prevetmed.2016.12.010] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/21/2016] [Revised: 11/10/2016] [Accepted: 12/18/2016] [Indexed: 11/22/2022]
Abstract
Tick-borne disease in dogs is common in South-east Asia and includes babesiosis and ehrlichiosis. These diseases can be largely prevented by compliant use of tick preventive products. This study investigated knowledge of ticks and tick-borne disease and use of tick preventive agents by a large sample of dog owners in Hong Kong. A total of 492 valid questionnaires were completed by owners attending veterinary practices, approached by researchers at common dog-walking areas, or targeted via local social media sites for pet owners. A high proportion of respondents were aware of tick-borne disease (79%) and this correlated well with use of preventive products. However, 18% of owners did not use any protection, mainly due to lack of knowledge of the risk of disease. Targeted advice stressing the importance of tick protection use and frequent follow-up at veterinary clinics could help reduce the risk of tick-borne disease. It would be beneficial if veterinarians provided training of frontline staff at the clinics to ensure they provide essential information to clients in an easily understandable format.
Collapse
|
5
|
Wagner B, Johnson J, Garcia-Tapia D, Honsberger N, King V, Strietzel C, Hardham JM, Heinz TJ, Marconi RT, Meeus PFM. Comparison of effectiveness of cefovecin, doxycycline, and amoxicillin for the treatment of experimentally induced early Lyme borreliosis in dogs. BMC Vet Res 2015. [PMID: 26205247 PMCID: PMC4513938 DOI: 10.1186/s12917-015-0475-9] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/31/2022] Open
Abstract
Background While Koch’s postulates have been fulfilled for Lyme disease; causing transient fever, anorexia and arthritis in young dogs; treatment of sero-positive dogs, especially asymptomatic animals, remains a topic of debate. To complicate this matter the currently recommended antibiotic treatments of Lyme Disease in dogs caused by Borrelia burgdorferi require daily oral administrations for 31 days or longer, which makes non-compliance a concern. Additionally, there is no approved veterinary antimicrobial for the treatment of Lyme Disease in dogs in the USA and few recommended treatments have been robustly tested. In vitro testing of cefovecin, a novel extended-spectrum cephalosporin, demonstrated inhibition of spirochete growth. A small pilot study in dogs indicated that two cefovecin injections two weeks apart would be as efficacious against B. burgdorferi sensu stricto as the recommended treatments using doxycycline or amoxicillin daily for 31 days. This hypothesis was tested in 17–18 week old Beagle dogs, experimentally infected with B. burgdorferi sensu stricto, using wild caught ticks, 75 days prior to antimicrobial administration. Results Clinical observations for lameness were performed daily but were inconclusive as this characteristic sign of Lyme Disease rarely develops in the standard laboratory models of experimentally induced infection. However, each antibiotic tested was efficacious against B. burgdorferi as measured by a rapid elimination of spirochetes from the skin and reduced levels of circulating antibodies to B. burgdorferi. In addition, significantly less cefovecin treated animals had Lyme Disease associated histopathological changes compared to untreated dogs. Conclusions Convenia was efficacious against B. burgdorferi sensu stricto infection in dogs as determined by serological testing, PCR and histopathology results. Convenia provides an additional and effective treatment option for Lyme Disease in dogs.
Collapse
Affiliation(s)
- Bettina Wagner
- Department of Population Medicine and Diagnostic Sciences, College of Veterinary Medicine, Cornell University, Ithaca, NY, USA.
| | - John Johnson
- Veterinary Medicine Research and Development, Zoetis, 333 Portage Street, Kalamazoo, MI, 49007, USA.
| | - David Garcia-Tapia
- Veterinary Medicine Research and Development, Zoetis, 333 Portage Street, Kalamazoo, MI, 49007, USA.
| | - Nicole Honsberger
- Veterinary Medicine Research and Development, Zoetis, 333 Portage Street, Kalamazoo, MI, 49007, USA.
| | - Vickie King
- Veterinary Medicine Research and Development, Zoetis, 333 Portage Street, Kalamazoo, MI, 49007, USA.
| | - Catherine Strietzel
- Veterinary Medicine Research and Development, Zoetis, 333 Portage Street, Kalamazoo, MI, 49007, USA.
| | - John M Hardham
- Veterinary Medicine Research and Development, Zoetis, 333 Portage Street, Kalamazoo, MI, 49007, USA.
| | - Thomas J Heinz
- Veterinary Medicine Research and Development, Zoetis, 333 Portage Street, Kalamazoo, MI, 49007, USA.
| | - Richard T Marconi
- Department of Microbiology and Immunology, Virginia Commonwealth University Medical Center, Richmond, PO Box 980678, VA, 23298, USA.
| | - Patrick F M Meeus
- Veterinary Medicine Research and Development, Zoetis, 333 Portage Street, Kalamazoo, MI, 49007, USA.
| |
Collapse
|
6
|
Beco L, Guaguère E, Lorente Méndez C, Noli C, Nuttall T, Vroom M. Suggested guidelines for using systemic antimicrobials in bacterial skin infections: part 2-- antimicrobial choice, treatment regimens and compliance. Vet Rec 2013; 172:156-60. [PMID: 23292948 PMCID: PMC3582090 DOI: 10.1136/vr.101070] [Citation(s) in RCA: 59] [Impact Index Per Article: 5.4] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 12/05/2012] [Indexed: 11/04/2022]
Abstract
Systemic antimicrobials are critically important in veterinary healthcare, and resistance is a major concern. Antimicrobial stewardship will be important in maintaining clinical efficacy by reducing the development and spread of antimicrobial resistance. Bacterial skin infections are one of the most common reasons for using systemic antimicrobials in dogs and cats. Appropriate management of these infections is, therefore, crucial in any policy for responsible antimicrobial use. The goals of therapy are to confirm that an infection is present, identify the causative bacteria, select the most appropriate antimicrobial, ensure that the infection is treated correctly, and to identify and manage any underlying conditions. This is the second of two articles that provide evidence-led guidelines to help practitioners address these issues. Part 1 discussed the use of clinical signs, cytology and culture in diagnosis. This article will cover the rationale for topical and systemic antimicrobial therapy, including choice of first-, second- and third-line drugs, the dose, duration of therapy, compliance and identification of underlying predisposing conditions. In addition, there is guidance on cases of therapeutic failure and environmental hygiene. These guidelines will help veterinarians avoid the development and propagation of antimicrobial-resistant bacterial strains.
Collapse
Affiliation(s)
- L Beco
- Cabinet Vétérinaire, Spa, Belgium
| | | | | | | | | | | |
Collapse
|
7
|
Animal Health Markets and Opportunities: Companion Animal Landscape. ADVANCES IN DELIVERY SCIENCE AND TECHNOLOGY 2013. [DOI: 10.1007/978-1-4614-4439-8_2] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/05/2022]
|
8
|
Stanneck D, Ebbinghaus-Kintscher U, Schoenhense E, Kruedewagen EM, Turberg A, Leisewitz A, Jiritschka W, Krieger KJ. The synergistic action of imidacloprid and flumethrin and their release kinetics from collars applied for ectoparasite control in dogs and cats. Parasit Vectors 2012; 5:73. [PMID: 22498105 PMCID: PMC3361670 DOI: 10.1186/1756-3305-5-73] [Citation(s) in RCA: 39] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/17/2012] [Accepted: 04/12/2012] [Indexed: 11/22/2022] Open
Abstract
Background The control of tick and flea burdens in dogs and cats has become essential to the control of important and emerging vector borne diseases, some of which are zoonoses. Flea worry and flea bite hypersensitivity are additionally a significant disease entity in dogs and cats. Owner compliance in maintaining the pressure of control measures has been shown to be poor. For these reasons efforts are continuously being made to develop ectoparasiticides and application methods that are safe, effective and easy to apply for pet owners. A new polymer matrix collar has recently been developed which is registered for 8 months use in cats and dogs. The basic properties of this collar have been investigated in several in vitro and in vivo studies. Methods The effects of imidacloprid, flumethrin and the combination were evaluated in vitro by means of whole cell voltage clamp measurement experiments conducted on isolated neuron cells from Spodoptera frugiperda. The in vitro efficacy of the two compounds and the combination against three species of ticks and their life stages and fleas were evaluated in a dry surface glass vial assay. The kinetics of the compounds over time in the collar were evaluated by the change in mass of the collar and measurement of the surface concentrations and concentrations of the actives in the collar matrix by HPLC. Hair clipped from collar treated dogs and cats, collected at various time points, was used to assess the acaricidal efficacy of the actives ex vivo. Results An in vitro isolated insect nerve model demonstrated the synergistic neurotoxic effects of the pyrethroid flumethrin and the neonicotinoid imidacloprid. An in vitro glass vial efficacy and mortality study against various life stages of the ticks Ixodes ricinus, Rhipicephalus sanguineus and Dermacentor reticulatus and against the flea (Ctenocephalides felis) demonstrated that the combination of these products was highly effective against these parasites. The release kinetics of these actives from a neck collar (compounded with 10% imidacloprid and 4.5% flumethrin) was extensively studied in dogs and cats under laboratory and field conditions. Acaricidal concentrations of the actives were found to be consistently released from the collar matrix for 8 months. None of the collar studies in dogs or cats were associated with any significant collar related adverse event. Conclusion Here we demonstrated the synergism between the pyrethroid flumethrin and the neonicotinoid imidacloprid, both provided in therapeutically relevant doses by a slow release collar matrix system over 8 months. This collar is therefore a convenient and safe tool for a long-term protection against ectoparasites.
Collapse
|